BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38159985)

  • 1. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer.
    Wakatsuki K; Matsumoto S; Migita K; Ito M; Kunishige T; Nakade H; Nakatani M; Kitano M; Sho M
    World J Surg; 2017 Aug; 41(8):2068-2077. PubMed ID: 28321554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.
    Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Washizawa N; Kaneko H
    Int J Clin Oncol; 2017 Jun; 22(3):461-468. PubMed ID: 28064398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte to Monocyte Ratio Is an Independent Prognostic Factor in Patients With Esophageal Cancer Who Receive Curative Treatment.
    Aoyama T; Kato A; Maezawa Y; Hashimoto I; Hara K; Komori K; Kawahara S; Numata M; Kazama K; Sawazaki S; Kamiya N; Yoshizawa S; Otani K; Tamagawa A; Cho H; Tamagawa H; Oshima T; Yukawa N; Saito A; Rino Y
    Anticancer Res; 2024 Jan; 44(1):339-346. PubMed ID: 38159996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
    In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
    Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
    Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma.
    Gulben K; Irkin F; Yazı M; BerberoGlu U
    Neoplasma; 2017; 64(1):131-135. PubMed ID: 27881014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.
    Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    In Vivo; 2020; 34(4):2021-2027. PubMed ID: 32606176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
    Huang W; Wu L; Liu X; Long H; Rong T; Ma G
    J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geriatric Nutritional Risk Index Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.
    Kato A; Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Numata M; Sawazaki S; Tamagawa A; Cho H; Morita J; Tanabe M; Kamiya N; Tamagawa H; Otani K; Kawahara S; Oshima T; Yukawa N; Saito A; Rino Y
    Anticancer Res; 2024 Jan; 44(1):331-337. PubMed ID: 38159974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.
    Yukawa N; Aoyama T; Tamagawa H; Tamagawa A; Atsumi Y; Kawahara S; Maezawa Y; Kano K; Murakawa M; Kazama K; Numata M; Oshima T; Masuda M; Rino Y
    In Vivo; 2020; 34(4):2087-2093. PubMed ID: 32606187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
    Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
    Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
    J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.